KBC Securities - Hyloris Pharmaceuticals (HYL) Morning Notes : HYL BB

Report

KBC Securities

Hilde Van Boxstael ...

Jacob Mekhael
Wim Lewi

Morning Notes : HYL BB

: HYL BB

13/05/2024 1 EN

Underlying

Hyloris Pharmaceuticals

See profile

BE0974363955 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Hilde Van Boxstael

Jacob Mekhael

Wim Lewi

Other Reports on these Companies

KBC Securities

Morning Notes : HYL BB, IBAB BB, PROX BB

: HYL BB, IBAB BB, PROX BB

September 16, 2024 September 16, 2024 1 EN

KBC Securities

Morning Notes : ARGX BB, HYL BB

: ARGX BB, HYL BB

August 19, 2024 August 19, 2024 1 EN

KBC Securities

Hyloris FIRST LOOK: Pipeline extends into veterinary medicine

Hyloris adds a new asset to the pipeline that is geared toward veterinary medicine. HY-095 is long-acting injectable formulation of a well-known proton pump inhibitor for the treatment of equine gastric ulcer syndrome, allowing more reliable drug delivery and lower dosing frequency vs. existing orals. Together with its partner, Hyloris will fund development costs and manage clinical trials in exchange for a 90%/10% profit sharing. We reiterate our € 5 TP and Hold rating.

August 19, 2024 August 19, 2024 1 EN

VGP EPRA property tour to Berlin Ludwigsfelde

We visited Lidl and Zalando warehouse on the VGP Berlin park Ludwigsfelde (216k sqm). These are standard buildings of 12m high and 7 ton floor. Interestingly, there is a lot of manual labour, with an estimated 80% of labour coming out of Poland. The Polish border is 100km away and workers stay the week nearby in local housing to go back home for the weekend. The Ludwigsfelde site is about 20km out of Berlin on the A10, a big industrial artery (Tesla, etc…). VGP bought the land in 2014 and is still developing land there. See map of the VGP Berlin park below. Most tenants appear e-commerce rela...

9h / 34m 9h / 34m 1 EN

Jacob Mekhael

Jacob Mekhael

MaaT Pharma 1H24 update extends runway into 2Q25, MaaT013 phase 3 topline in 4Q24

MaaT reported 1H24 results, which come with an extension of the company's cash runway into 2Q25 (from 1Q25) through prioritisation of resources on the key programs for MaaT013 and MaaT033, while management confirmed they are exploring all options for additional funding. In addition, the company reiterates the timeline for the topline results from the phase 3 (ARES) trial of MaaT013 in aGvHD in Europe, which continue to be expected in mid-4Q24 – we view this as an important trigger for the company with a high probability of success based on the solid phase 2 results and early access program dat...

9h / 45m 9h / 45m 1 EN

Guy Sips ... (+5)

Guy Sips
Hilde Van Boxstael
Jacob Mekhael
Michiel Declercq
Wim Lewi

Morning Notes : BARb BB, OPTI BB, GIMBb BB, VGP BB, MAAT FP

: BARb BB, OPTI BB, GIMBb BB, VGP BB, MAAT FP

9h / 47m 9h / 47m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Morning Notes : HYL BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : HYL BB, IBAB BB, PROX BB

Morning Notes : ARGX BB, HYL BB

Hyloris FIRST LOOK: Pipeline extends into veterinary medicine

VGP EPRA property tour to Berlin Ludwigsfelde

MaaT Pharma 1H24 update extends runway into 2Q25, MaaT013 phase 3 topline in 4Q24

Morning Notes : BARb BB, OPTI BB, GIMBb BB, VGP BB, MAAT FP

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe